Covered recipient · General Payments record
SUSAN DAVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$667.84
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $378.65 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $248.20 | 3 |
| Teva Pharmaceuticals USA, Inc. | $53.98 | 2 |
| Vanda Pharmaceuticals Inc. | $23.46 | 1 |
| ITI, Inc. | $23.15 | 1 |
| Indivior Inc. | $15.48 | 1 |
| Invivyd Inc | $14.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Indivior Inc. | $15.48 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144549369 | CMS |
| Invivyd Inc | $14.38 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147384825 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.15 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143422832 | CMS |
| Supernus Pharmaceuticals, Inc. | $230.57 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147867974 | CMS |
| Supernus Pharmaceuticals, Inc. | $5.23 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147867970 | CMS |
| Supernus Pharmaceuticals, Inc. | $12.40 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147867972 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.98 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151507411 | CMS |
| Teva Pharmaceuticals USA, Inc. | $29.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151507453 | CMS |
| Vanda Pharmaceuticals Inc. | $23.46 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133938690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.